J. Lipid Res.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Greeve, J.
Right arrow Articles by Windler, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Greeve, J.
Right arrow Articles by Windler, E.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Journal of Lipid Research, Vol 34, 1367-1383, Copyright © 1993 by Lipid Research, Inc.

ARTICLES

Apolipoprotein B mRNA editing in 12 different mammalian species: hepatic expression is reflected in low concentrations of apoB- containing plasma lipoproteins

J Greeve, I Altkemper, JH Dieterich, H Greten and E Windler
Medizinische Kernklinik und Poliklinik, Universitats-Krankenhaus Eppendorf, Hamburg, Germany.

Two different isoproteins are encoded by the apolipoprotein (apo) B gene, apoB-48 and apoB-100. ApoB-48, core component of intestinally derived chylomicrons, has an accelerated plasma turnover as compared with the full-length protein apoB-100. A posttranscriptional modification of the apoB mRNA by conversion of cytidine into uridine at nucleotide position 6666 changes the genomically encoded glutamine codon CAA at amino acid residue 2153 into a translational stop codon UAA. This mRNA editing explains the formation of the truncated isoform apoB-48. In the present investigation editing of apoB mRNA in liver and intestine from 12 different mammalian species was measured by a quantitative primer extension analysis of reverse-transcribed and polymerase chain reaction- (PCR) amplified apoB mRNA in order to determine whether i) editing of apoB mRNA is generally restricted to the intestine or may also be found in the liver of other species than rodents, and ii) hepatic expression of apoB mRNA editing influences lipoprotein concentrations in plasma. Intestinal apoB mRNA was edited at high levels in all species, 40% in sheep, 73% in horse, 82% in pig, 84% in dog, 84% in cat, 87% in guinea pig, 88% in rat, 89% in mouse, and > 90% in human, monkey, cow, and rabbit. In liver apoB mRNA was edited to 18% in dog, to 43% in horse, to 62% in rat, and to 70% in mouse. Low levels of editing below 1% were detected in liver of rabbit and guinea pig. In contrast, hepatic apoB mRNA from human, monkey, pig, cow, sheep, and cat liver was not edited. The results of the primer extension analysis were confirmed by cloning and sequencing of the PCR products from dog, horse, cat, guinea pig, sheep, and cow for all of which the apoB cDNA sequence had not been established by previous investigations. Primer extension analysis of apoB mRNA from dog intestine and dog liver indicated C/U editing at C6655 in addition to C6666. Cloning and sequencing of apoB cDNA from dog liver and intestine confirmed additional C/U editing at C6655 which changes ACA for threonine at amino acid residue 2149 into AUA for isoleucine. Synthesis and secretion of apoB-48-containing lipoproteins from liver was demonstrated by pulse labeling of freshly isolated horse hepatocytes and immunoprecipitation with apoB-specific antibodies or density gradient ultracentrifugation. The concentrations of VLDL, LDL, and HDL in all species were determined after fractionation by density gradient ultracentrifugation.(ABSTRACT TRUNCATED AT 400 WORDS)
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 DiabetesHome page
L. Qiao, C. Zou, D. R. van der Westhuyzen, and J. Shao
Adiponectin Reduces Plasma Triglyceride by Increasing VLDL Triglyceride Catabolism
Diabetes, July 1, 2008; 57(7): 1824 - 1833.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
D. J. Lloyd, J. McCormick, J. Helmering, K. W. Kim, M. Wang, P. Fordstrom, S. A. Kaufman, R. A. Lindberg, and M. M. Veniant
Generation and characterization of two novel mouse models exhibiting the phenotypes of the metabolic syndrome: Apob48-/-Lepob/ob mice devoid of ApoE or Ldlr
Am J Physiol Endocrinol Metab, March 1, 2008; 294(3): E496 - E505.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
M. J. Graham, K. M. Lemonidis, C. P. Whipple, A. Subramaniam, B. P. Monia, S. T. Crooke, and R. M. Crooke
Antisense inhibition of proprotein convertase subtilisin/kexin type 9 reduces serum LDL in hyperlipidemic mice
J. Lipid Res., April 1, 2007; 48(4): 763 - 767.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
D. M. Lehmann, C. A. Galloway, M. P. Sowden, and H. C. Smith
Metabolic regulation of ApoB mRNA editing is associated with phosphorylation of APOBEC-1 complementation factor
Nucleic Acids Res., July 4, 2006; 34(11): 3299 - 3308.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
I. Grosskopf, N. Baroukh, S.-J. Lee, Y. Kamari, D. Harats, E. M. Rubin, L. A. Pennacchio, and A. D. Cooper
Apolipoprotein A-V Deficiency Results in Marked Hypertriglyceridemia Attributable to Decreased Lipolysis of Triglyceride-Rich Lipoproteins and Removal of Their Remnants
Arterioscler. Thromb. Vasc. Biol., December 1, 2005; 25(12): 2573 - 2579.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
X. Lin, P. Yue, Y. Xie, N. O. Davidson, N. Sakata, R. E. Ostlund Jr., Z. Chen, and G. Schonfeld
Reduced intestinal fat absorptive capacity but enhanced susceptibility to diet-induced fatty liver in mice heterozygous for ApoB38.9 truncation
Am J Physiol Gastrointest Liver Physiol, July 1, 2005; 289(1): G146 - G152.
[Abstract] [Full Text] [PDF]

Home page
 RNAHome page
C. MARIS, J. MASSE, A. CHESTER, N. NAVARATNAM, and F. H.-T. ALLAIN
NMR structure of the apoB mRNA stem-loop and its interaction with the C to U editing APOBEC1 complementary factor
RNA, February 1, 2005; 11(2): 173 - 186.
[Abstract] [Full Text] [PDF]

Home page
 J ANIM SCIHome page
N. Frank, J. E. Sojka, and M. A. Latour
Effect of hypothyroidism on the blood lipid response to higher dietary fat intake in mares
J Anim Sci, September 1, 2004; 82(9): 2640 - 2646.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. P. Sowden, D. M. Lehmann, X. Lin, C. O. Smith, and H. C. Smith
Identification of Novel Alternative Splice Variants of APOBEC-1 Complementation Factor with Different Capacities to Support Apolipoprotein B mRNA Editing
J. Biol. Chem., January 2, 2004; 279(1): 197 - 206.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
Z. Chen, R. L. Fitzgerald, G. Li, N. O. Davidson, and G. Schonfeld
Hepatic secretion of apoB-100 is impaired in hypobetalipoproteinemic mice with an apoB-38.9-specifying allele
J. Lipid Res., January 1, 2004; 45(1): 155 - 163.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
Y. Xie, F. Nassir, J. Luo, K. Buhman, and N. O. Davidson
Intestinal lipoprotein assembly in apobec-1-/- mice reveals subtle alterations in triglyceride secretion coupled with a shift to larger lipoproteins
Am J Physiol Gastrointest Liver Physiol, October 1, 2003; 285(4): G735 - G746.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
J. Greeve, A. Philipsen, K. Krause, W. Klapper, K. Heidorn, B. E. Castle, J. Janda, K. B. Marcu, and R. Parwaresch
Expression of activation-induced cytidine deaminase in human B-cell non-Hodgkin lymphomas
Blood, May 1, 2003; 101(9): 3574 - 3580.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
Z. Chen, R. L. Fitzgerald, J. E. Saffitz, C. F. Semenkovich, and G. Schonfeld
Amino Terminal 38.9% of Apolipoprotein B-100 Is Sufficient to Support Cholesterol-Rich Lipoprotein Production and Atherosclerosis
Arterioscler. Thromb. Vasc. Biol., April 1, 2003; 23(4): 668 - 674.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
H. Lellek, S. Welker, I. Diehl, R. Kirsten, and J. Greeve
Reconstitution of mRNA Editing in Yeast Using a Gal4-ApoB-Gal80 Fusion Transcript as the Selectable Marker
J. Biol. Chem., June 21, 2002; 277(26): 23638 - 23644.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
M. A. Ostos, D. Recalde, N. Baroukh, A. Callejo, M. Rouis, G. Castro, and M. M. Zakin
Fructose Intake Increases Hyperlipidemia and Modifies Apolipoprotein Expression in Apolipoprotein AI-CIII-AIV Transgenic Mice
J. Nutr., May 1, 2002; 132(5): 918 - 923.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
G. S. C. Dance, M. P. Sowden, L. Cartegni, E. Cooper, A. R. Krainer, and H. C. Smith
Two Proteins Essential for Apolipoprotein B mRNA Editing Are Expressed from a Single Gene through Alternative Splicing
J. Biol. Chem., April 5, 2002; 277(15): 12703 - 12709.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
D. L. Gillian-Daniel, P. W. Bates, A. Tebon, and A. D. Attie
Endoplasmic reticulum localization of the low density lipoprotein receptor mediates presecretory degradation of apolipoprotein B
PNAS, April 2, 2002; 99(7): 4337 - 4342.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
Y. Yang, N. Ballatori, and H. C. Smith
Apolipoprotein B mRNA Editing and the Reduction in Synthesis and Secretion of the Atherogenic Risk Factor, Apolipoprotein B100 Can Be Effectively Targeted through TAT-Mediated Protein Transduction
Mol. Pharmacol., February 1, 2002; 61(2): 269 - 276.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
M. L. Fernandez
Guinea Pigs as Models for Cholesterol and Lipoprotein Metabolism
J. Nutr., January 1, 2001; 131(1): 10 - 20.
[Abstract] [Full Text]

Home page
 J. Lipid Res.Home page
R. B. Weinberg, R. A. Anderson, V. R. Cook, F. Emmanuel, P. Denefle, M. Hermann, and A. Steinmetz
Structure and interfacial properties of chicken apolipoprotein A-IV
J. Lipid Res., September 1, 2000; 41(9): 1410 - 1418.
[Abstract] [Full Text]

Home page
 J. Nutr.Home page
S. K. Reaves, J. Y. J. Wu, Y. Wu, J. C. Fanzo, Y. R. Wang, P. P. Lei, and K. Y. Lei
Regulation of Intestinal Apolipoprotein B mRNA Editing Levels by a Zinc-Deficient Diet and cDNA Cloning of Editing Protein in Hamsters
J. Nutr., September 1, 2000; 130(9): 2166 - 2173.
[Abstract] [Full Text]

Home page
 Mol. Cell. Biol.Home page
A. Mehta, M. T. Kinter, N. E. Sherman, and D. M. Driscoll
Molecular Cloning of Apobec-1 Complementation Factor, a Novel RNA-Binding Protein Involved in the Editing of Apolipoprotein B mRNA
Mol. Cell. Biol., March 1, 2000; 20(5): 1846 - 1854.
[Abstract] [Full Text]

Home page
 Nucleic Acids ResHome page
G. S. C. Dance, M. P. Sowden, Y. Yang, and H. C. Smith
APOBEC-1 dependent cytidine to uridine editing of apolipoprotein B RNA in yeast
Nucleic Acids Res., January 15, 2000; 28(2): 424 - 429.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. Hersberger, S. Patarroyo-White, K. S. Arnold, and T. L. Innerarity
Phylogenetic Analysis of the Apolipoprotein B mRNA-editing Region. EVIDENCE FOR A SECONDARY STRUCTURE BETWEEN THE MOORING SEQUENCE AND THE 3' EFFICIENCY ELEMENT
J. Biol. Chem., December 3, 1999; 274(49): 34590 - 34597.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
Y. Huang, Z.-S. Ji, W. J. Brecht, S. C. Rall Jr, J. M. Taylor, and R. W. Mahley
Overexpression of Apolipoprotein E3 in Transgenic Rabbits Causes Combined Hyperlipidemia by Stimulating Hepatic VLDL Production and Impairing VLDL Lipolysis
Arterioscler. Thromb. Vasc. Biol., December 1, 1999; 19(12): 2952 - 2959.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
J. Wu, Y. H. Zhu, and S. B. Patel
Cyclosporin-induced dyslipoproteinemia is associated with selective activation of SREBP-2
Am J Physiol Endocrinol Metab, December 1, 1999; 277(6): E1087 - E1094.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
R. A. K. Srivastava, N. Srivastava, M. Averna, A. B. Cefalu, and G. Schonfeld
Molecular bases of low production rates of apolipoprotein B-100 and truncated apoB-82 in a mutant HepG2 cell line generated by targeted modification of the apolipoprotein B gene
J. Lipid Res., May 1, 1999; 40(5): 901 - 912.
[Abstract] [Full Text]

Home page
 J. Lipid Res.Home page
M. E. Brousseau and J. M. Hoeg
Transgenic rabbits as models for atherosclerosis research
J. Lipid Res., March 1, 1999; 40(3): 365 - 375.
[Abstract] [Full Text]

Home page
 J. Nutr.Home page
M. M. Veniant, E. Kim, S. McCormick, J. Boren, L. B. Nielsen, M. Raabe, and S. G. Young
Insights into Apolipoprotein B Biology from Transgenic and Gene-Targeted Mice
J. Nutr., February 1, 1999; 129(2): 451 - 451.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
N. Richardson, N. Navaratnam, and J. Scott
Secondary Structure for the Apolipoprotein B mRNA Editing Site. AU-BINDING PROTEINS INTERACT WITH A STEM LOOP
J. Biol. Chem., November 27, 1998; 273(48): 31707 - 31717.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
J. Greeve, D. Axelos, S. Welker, M. Schipper, and H. Greten
Distinct Promoters Induce APOBEC-1 Expression in Rat Liver and Intestine
Arterioscler. Thromb. Vasc. Biol., July 1, 1998; 18(7): 1079 - 1092.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
X. Qian, M. E. Balestra, S. Yamanaka, J. Boren, I. Lee, and T. L. Innerarity
Low Expression of the Apolipoprotein B mRNA–Editing Transgene in Mice Reduces LDL Levels but Does Not Cause Liver Dysplasia or Tumors
Arterioscler. Thromb. Vasc. Biol., June 1, 1998; 18(6): 1013 - 1020.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. Hersberger and T. L. Innerarity
Two Efficiency Elements Flanking the Editing Site of Cytidine 6666 in the Apolipoprotein B mRNA Support Mooring-dependent Editing
J. Biol. Chem., April 17, 1998; 273(16): 9435 - 9442.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
E. Kim and S. G. Young
Genetically modified mice for the study of apolipoprotein B
J. Lipid Res., April 1, 1998; 39(4): 703 - 723.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
X. Qian, M. E. Balestra, and T. L. Innerarity
Two Distinct TATA-less Promoters Direct Tissue-specific Expression of the Rat Apo-B Editing Catalytic Polypeptide 1 Gene
J. Biol. Chem., July 18, 1997; 272(29): 18060 - 18070.
[Abstract] [Full Text] [PDF]

Home page
 Genes Dev.Home page
S Yamanaka, K S Poksay, K S Arnold, and T L Innerarity
A novel translational repressor mRNA is edited extensively in livers containing tumors caused by the transgene expression of the apoB mRNA-editing enzyme.
Genes & Dev., February 1, 1997; 11(3): 321 - 333.
[Abstract] [PDF]

Home page
 J. Biol. Chem.Home page
M. Nakamuta, B. H.-J. Chang, E. Zsigmond, K. Kobayashi, H. Lei, B. Y. Ishida, K. Oka, E. Li, and L. Chan
Complete Phenotypic Characterization of apobec-1 Knockout Mice with a Wild-type Genetic Background and a Human Apolipoprotein B Transgenic Background, and Restoration of Apolipoprotein B mRNA Editing by Somatic Gene Transfer of Apobec-1
J. Biol. Chem., October 18, 1996; 271(42): 25981 - 25988.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
R. S. McLeod, Y. Wang, S. Wang, A. Rusinol, P. Links, and Z. Yao
Apolipoprotein B Sequence Requirements for Hepatic Very Low Density Lipoprotein Assembly. EVIDENCE THAT HYDROPHOBIC SEQUENCES WITHIN APOLIPOPROTEIN B48 MEDIATE LIPID RECRUITMENT
J. Biol. Chem., August 2, 1996; 271(31): 18445 - 18455.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
P. Sivaram, T. Vanni-Reyes, and I. J. Goldberg
Endothelial Cells Synthesize and Process Apolipoprotein B
J. Biol. Chem., June 21, 1996; 271(25): 15261 - 15266.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. Yamanaka, K. S. Poksay, D. M. Driscoll, and T. L. Innerarity
Hyperediting of Multiple Cytidines of Apolipoprotein B mRNA by APOBEC-1 Requires Auxiliary Protein(s) but Not a Mooring Sequence Motif
J. Biol. Chem., May 10, 1996; 271(19): 11506 - 11510.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
K.-I. Hirano, S. G. Young, R. V. Farese Jr., J. Ng, E. Sande, C. Warburton, L. M. Powell-Braxton, and N. O. Davidson
Targeted Disruption of the Mouse apobec-1 Gene Abolishes Apolipoprotein B mRNA Editing and Eliminates Apolipoprotein B48
J. Biol. Chem., April 26, 1996; 271(17): 9887 - 9890.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. Sowden, J. K. Hamm, and H. C. Smith
Overexpression of APOBEC-1 Results in Mooring Sequence-dependent Promiscuous RNA Editing
J. Biol. Chem., February 9, 1996; 271(6): 3011 - 3017.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
T. L. Innerarity, J. Borén, S. Yamanaka, and S.-O. Olofsson
Biosynthesis of Apolipoprotein B48-containing Lipoproteins
J. Biol. Chem., February 2, 1996; 271(5): 2353 - 2356.
[Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
J. Fan, S. P.A. McCormick, R. M. Krauss, S. Taylor, R. Quan, J. M. Taylor, and S. G. Young
Overexpression of Human Apolipoprotein B-100 in Transgenic Rabbits Results in Increased Levels of LDL and Decreased Levels of HDL
Arterioscler. Thromb. Vasc. Biol., November 1, 1995; 15(11): 1889 - 1899.
[Abstract] [Full Text]

Home page
 J. Biol. Chem.Home page
M. Nakamuta, K. Oka, J. Krushkal, K. Kobayashi, M. Yamamoto, W.-H. Li, and L. Chan
Alternative mRNA Splicing and Differential Promoter Utilization Determine Tissue-specific Expression of the Apolipoprotein B mRNA-editing Protein (Apobec1) Gene in Mice
J. Biol. Chem., June 2, 1995; 270(22): 13042 - 13056.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
M. M. Hussain, Y. Zhao, R. K. Kancha, B. D. Blackhart, and Z. Yao
Characterization of Recombinant Human ApoB-48–Containing Lipoproteins in Rat Hepatoma McA-RH7777 Cells Transfected With ApoB-48 cDNA : Overexpression of ApoB-48 Decreases Synthesis of Endogenous ApoB-100
Arterioscler. Thromb. Vasc. Biol., April 1, 1995; 15(4): 485 - 494.
[Abstract] [Full Text]

Home page
 J. Biol. Chem.Home page
H. Lellek, R. Kirsten, I. Diehl, F. Apostel, F. Buck, and J. Greeve
Purification and Molecular Cloning of a Novel Essential Component of the Apolipoprotein B mRNA Editing Enzyme-Complex
J. Biol. Chem., June 23, 2000; 275(26): 19848 - 19856.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Z. Chen, R. L. Fitzgerald, M. R. Averna, and G. Schonfeld
A Targeted Apolipoprotein B-38.9-producing Mutation Causes Fatty Livers in Mice Due to the Reduced Ability of Apolipoprotein B-38.9 to Transport Triglycerides
J. Biol. Chem., October 13, 2000; 275(42): 32807 - 32815.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
V. Blanc, N. Navaratnam, J. O. Henderson, S. Anant, S. Kennedy, A. Jarmuz, J. Scott, and N. O. Davidson
O|Identification of GRY-RBP as an Apolipoprotein B RNA-binding Protein That Interacts with Both Apobec-1 and Apobec-1 Complementation Factor to Modulate C to U Editing
J. Biol. Chem., March 23, 2001; 276(13): 10272 - 10283.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
D. L. Gillian-Daniel, P. W. Bates, A. Tebon, and A. D. Attie
Endoplasmic reticulum localization of the low density lipoprotein receptor mediates presecretory degradation of apolipoprotein B
PNAS, April 2, 2002; 99(7): 4337 - 4342.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 1993 by the American Society for Biochemistry and Molecular Biology.